Just to add a little more speculation on the conference presentation I asked Imugene the following questions and received the response from Nick Ede today.
In regards to the 2024 Cholangiocarcinoma Foundation Annual Conference I would like to ask, is it normal for a biotech to be SELECTED for a conference of this type?Also is it common to be presenting an oral presentation as well as presenting a poster?
Regards Hawkbar33
Hi Hawkbar33,
We already had a poster accepted and we were "invited" to give a short oral presentation in addition. This is somewhat unusual so we are excited to have the opportunity to expand on the poster in an oral format to all the doctors and interested parties who will be present.
Best regards,Nick Ede
While I wouldn't put too much emphasis on the response I think Imugene are looking forward to expanding on the poster presentation.
DYOR opinion only
Why IMU is a multi multi bagger, page-22392
-
- There are more pages in this discussion • 4,942 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.4¢ | $417.0K | 9.281M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6074903 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 362283 | 5 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |